Sponsor pipeline

Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita) clinical trial pipeline

Get alerts when Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable

    Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist in Controlled Ovarian Stimulation for In Vitro Fertilization: A Randomized Controlled Non-Inferiority Trial With a Concurrent Comparator Cohort Undergoing Progestin-Primed Ovarian Stimulation (PPOS)

    Enrollment reduced: 195 → 120 participants

    Also in this update: Phase changed: not specified → not applicable; Interventions modified

    Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)Not applicable NCT07732348 Registry history of NCT07732348 on ClinicalTrials.gov (opens the registry)

    Updated

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Not applicable
NCT07732348 Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist in Controlled Ovarian… Infertility, Female Not Yet Recruiting 2026-09-30
Not specified
NCT07733713 Hysteroscopy and CD138+ Plasma Cell Density in Chronic Endometritis Chronic Endometritis Not Yet Recruiting 2026-07-29
Get alerts when Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free